Eikon Therapeutics is a biopharmaceutical company that is pioneering a new approach to drug discovery based on single-molecule tracking (SMT). The company's proprietary super-resolution microscopy platform allows it to visualize the real-time movement of individual proteins in living cells, enabling the development of novel therapeutics.
Hayward
CA
2019
201–500
